A comparison of treatment with ezetimibe (SCH 58235) and simvastatin coadministration versus simvastatin in attaining the national cholesterol education program (NCEP) adult treatment panel (ATP) III coronary heart disease (CHD) or CHD risk equivalent strata low-density lipoprotein cholesterol (LDL-C) target level

Trial Profile

A comparison of treatment with ezetimibe (SCH 58235) and simvastatin coadministration versus simvastatin in attaining the national cholesterol education program (NCEP) adult treatment panel (ATP) III coronary heart disease (CHD) or CHD risk equivalent strata low-density lipoprotein cholesterol (LDL-C) target level

Not stated
Phase of Trial: Clinical Phase Unknown

Latest Information Update: 02 Feb 2006

At a glance

  • Drugs Ezetimibe (Primary) ; Simvastatin
  • Indications Dyslipidaemias
  • Focus Therapeutic Use
  • Most Recent Events

    • 02 Feb 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top